CD19 antibody (PE)
Quick Overview for CD19 antibody (PE) (ABIN2704188)
Target
See all CD19 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Purpose
- CD19 PE Antibody
-
Characteristics
- The clone 4G7 recognizes a 90- kDa CD19 antigen that is present on human B lymphocytes. The CD19 antigen is present on approximately 7 to 23 % of human peripheral blood lymphocytes at all stages of B cell maturation but is lost on terminally differentiated plasma cells. CD19 does not react with resting or activated T lymphocytes, granulocytes, or monocytes.
-
Purification
- Purified
-
Purity
- >95 %
-
Immunogen
- Human CCL (chronic lymphocytic leukemia) cells
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 25 μg/mL
-
Buffer
- PBS pH 7.2, 0.2 % (w/v) BSA, 0.09 % (w/v) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- 2-8°C, Conjugated antibodies should never be frozen.
-
-
- CD19 (CD19 Molecule (CD19))
-
Alternative Name
- CD19
-
NCBI Accession
- NM_001770
-
UniProt
- P15391
-
Pathways
- Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
Target
-